R J Biotech

R J Biotech FCF Conversion

Delisted·Sep 16, 2026

The FCF Conversion Rate (FCF/EBITDA) of R J Biotech (536456.BO) as of Oct 18, 2026 is 51.50 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -11.77 % — a change of -537.57% (higher).

FCF Conversion

51.50 %

YoY

-537.57%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of R J Biotech is 2022 51.50 % . FCF Conversion Rate (FCF/EBITDA) of R J Biotech was 2021 -11.77 % . It decreases by -537.57% higher compared to the previous year.

The R J Biotech FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2015
160.32 INR
Jan 1, 2016
253.47 INR
Jan 1, 2017
0.17 INR
Jan 1, 2018
13.50 INR
Jan 1, 2019
-6.68 INR
Jan 1, 2020
-15.39 INR
Jan 1, 2021
-11.77 INR
Jan 1, 2022
51.50 INR
The R J Biotech FCF Conversion history
YEARFCF ConversionYoY
51.50 %-537.57%
-11.77 %-23.54%
-15.39 %+130.36%
-6.68 %-149.50%
13.50 %+7,810.47%
0.17 %-99.93%
253.47 %+58.11%
160.32 %-183.13%
-192.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

R J Biotech Stock analysis

What does R J Biotech do? R J Biotech Ltd, based in Aurangabad, India, operates in the Consumer Staples sector within the Food Products industry. The company specializes in research, development, and marketing of hybrid seeds for field crops, vegetable crops, and oilseed crops. It offers varieties such as Hybrid Bajra Amol, BG-II Cotton Hybrid Tukaram, and Elite Paddy Janaki-1010. With over 2,700 germplasm varieties and processing facilities capable of 45,000 MT annually, R J Biotech focuses on enhancing nutritional and economic traits in crops like cotton, paddy, maize, and vegetables. R J Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about R J Biotech stock

FCF Conversion Rate (FCF/EBITDA) of R J Biotech is 51.50 % in 2022.

FCF Conversion Rate (FCF/EBITDA) of R J Biotech changed from -11.77 % to 51.50 %, representing a -537.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) R J Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s R J Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — R J Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — R J Biotech